CORMORANT ASSET MANAGEMENT, LP – Viridian Therapeutics, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$26.86M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+77.27%
quarter
Viridian Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +49.29% | 432.5K shares | 16.71M | $20.51 | 1.31M |
| Q2 2022 | share | Decrease | -12.25% | -122.5K shares | -8.33M | $11.57 | 877.5K |
| Q1 2022 | share | Increase | +233.33% | 700K shares | 12.55M | $18.49 | 1M |
| Q4 2021 | share | Decrease | -12.42% | -42.56K shares | 296K | $20.3 | 300K |
| Q3 2021 | share | Decrease | -0.12% | -400 shares | -638K | $16.45 | 342.56K |
| Q2 2021 | share | Decrease | -25.30% | -116.18K shares | -1.39M | $18.29 | 342.96K |
| Q1 2021 | share | Increase | 0.00% | 459.14K shares | 7.67M | $16.71 | 459.14K |